|
|
|
Volumn 24, Issue 2 Suppl 6, 1997, Pages
|
|
The effect of YNK-01 (an oral prodrug of cytarabine) on hepatocellular carcinoma.
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
1 ARABINOFURANOSYLCYTOSINE 5' STEARYLPHOSPHATE;
1-ARABINOFURANOSYLCYTOSINE-5'-STEARYLPHOSPHATE;
ANTINEOPLASTIC AGENT;
ARABINONUCLEOTIDE;
CYTIDINE PHOSPHATE;
DRUG DERIVATIVE;
PRODRUG;
AGED;
ARTICLE;
CLINICAL TRIAL;
COMPUTER ASSISTED TOMOGRAPHY;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
FEMALE;
HUMAN;
LIVER CELL CARCINOMA;
LIVER TUMOR;
MALE;
MIDDLE AGED;
MULTICENTER STUDY;
ORAL DRUG ADMINISTRATION;
PATHOLOGY;
RADIOGRAPHY;
ADMINISTRATION, ORAL;
AGED;
ANTINEOPLASTIC AGENTS;
ARABINONUCLEOTIDES;
CARCINOMA, HEPATOCELLULAR;
CYTIDINE MONOPHOSPHATE;
FEMALE;
HUMANS;
LIVER NEOPLASMS;
MALE;
MIDDLE AGED;
PRODRUGS;
TOMOGRAPHY, X-RAY COMPUTED;
|
|
EID: 0031110575
PISSN: 00937754
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (1)
|
|
References (0)
|
